Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1985 1
1989 1
2002 4
2003 3
2004 1
2007 1
2009 1
2010 1
2011 1
2012 2
2015 1
2016 3
2017 2
2018 1
2019 3
2020 1
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma.
Drees EEE, Roemer MGM, Groenewegen NJ, Perez-Boza J, van Eijndhoven MAJ, Prins LI, Verkuijlen SAWM, Tran XM, Driessen J, Zwezerijnen GJC, Stathi P, Mol K, Karregat JJJP, Kalantidou A, Vallés-Martí A, Molenaar TJ, Aparicio-Puerta E, van Dijk E, Ylstra B, Groothuis-Oudshoorn CGM, Hackenberg M, de Jong D, Zijlstra JM, Pegtel DM. Drees EEE, et al. Among authors: molenaar tj. J Extracell Vesicles. 2021 Jul;10(9):e12121. doi: 10.1002/jev2.12121. Epub 2021 Jul 15. J Extracell Vesicles. 2021. PMID: 34295456 Free PMC article.
Dot1 promotes H2B ubiquitination by a methyltransferase-independent mechanism.
van Welsem T, Korthout T, Ekkebus R, Morais D, Molenaar TM, van Harten K, Poramba-Liyanage DW, Sun SM, Lenstra TL, Srivas R, Ideker T, Holstege FCP, van Attikum H, El Oualid F, Ovaa H, Stulemeijer IJE, Vlaming H, van Leeuwen F. van Welsem T, et al. Among authors: molenaar tm. Nucleic Acids Res. 2018 Nov 30;46(21):11251-11261. doi: 10.1093/nar/gky801. Nucleic Acids Res. 2018. PMID: 30203048 Free PMC article.
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma.
Vlaming H, McLean CM, Korthout T, Alemdehy MF, Hendriks S, Lancini C, Palit S, Klarenbeek S, Kwesi-Maliepaard EM, Molenaar TM, Hoekman L, Schmidlin TT, Altelaar AM, van Welsem T, Dannenberg JH, Jacobs H, van Leeuwen F. Vlaming H, et al. Among authors: molenaar tm. EMBO J. 2019 Jul 15;38(14):e101564. doi: 10.15252/embj.2019101564. Epub 2019 Jun 17. EMBO J. 2019. PMID: 31304633 Free PMC article.
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment.
Drees EEE, Jauw YWS, van Dijk E, Borchmann S, Verkuijlen SAWM, Stathi P, Groenewegen NJ, Hijmering NJ, Berry DRAI, Meershoek EJ, Hoogmoed D, Kwakman A, Molenaar TJ, Pegtel DM, Ylstra B, de Jong D, Zijlstra JM, Roemer MGM. Drees EEE, et al. Among authors: molenaar tj. Hemasphere. 2022 Jul 4;6(7):e749. doi: 10.1097/HS9.0000000000000749. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35813096 Free PMC article. No abstract available.
Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
van Mulligen E, de Jong PHP, Kuijper TM, van der Ven M, Appels C, Bijkerk C, Harbers JB, de Man Y, Molenaar THE, Tchetverikov I, Goekoop-Ruiterman YPM, van Zeben J, Hazes JMW, Weel AEAM, Luime JJ. van Mulligen E, et al. Among authors: molenaar the. Ann Rheum Dis. 2019 Jun;78(6):746-753. doi: 10.1136/annrheumdis-2018-214970. Epub 2019 Apr 6. Ann Rheum Dis. 2019. PMID: 30954969 Free article. Clinical Trial.
30 results